Speaker details

Biography

David Rockwell represents non-U.S. companies and financial institutions in connection with their corporate finance and mergers and acquisitions activities. In the corporate finance area, he has acted on behalf of both underwriters and issuers in connection with a wide range of high-profile equity and debt financing transactions. His recent equity experience includes representing UBS in connection with its implementation of a new holding company structure, as well as representing the issuers in numerous IPOs, including Braas Monier Building Group and LEG Immobilien. He has represented Porsche, ING, SEB, Anheuser-Busch InBev and UBS in connection with their various rights offerings, Evonik on its Frankfurt Stock Exchange listing and Anheuser-Busch InBev on its New York Stock Exchange listing. He has represented the underwriters in connection with the IPOs of IMCD N.V., Allied Minds PLC, and Countrywide PLC, among many others, as well as in connection with Commerzbank's 2013 equity rights offering, 2011 mandatory convertible bond offering and 2011 equity rights offering, the 2013 equity offering and Frankfurt Stock Exchange listing of the RTL Group, and the 2015 $6 billion Yankee bond issuance by AstraZeneca. Mr. Rockwell also regularly advises several European banks on U.S. regulatory matters. Mr. Rockwell is an officer of the IBA's Capital Markets Forum and immediate past Chairman of the IBA’s Securities Law Committee. He is a member of the Consultative Advisory Group of the International Auditing and Assurance Standards Board and a contributing editor to the IFLR. He is proficient in German and has a good working knowledge of Spanish.